Nuvectis Pharma to Participate in the Maxim Growth Summit 2026
Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of complement-related conditions and oncology, today announced that members of senior management will participate in the Maxim Growth Summit 2026 on Wednesday, October 14, 2026 in New York.
Covered in this story
Call it yourself
No calls on $NVCT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Nuvectis Pharma Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.